» Articles » PMID: 39705295

Dynamics of SARS-CoV-2 Lineages in Children and Adults in 2021 and 2022

Abstract

Purpose: We aimed to describe SARS-CoV-2 lineages and diversity in children and adults in Estonia and similarity to travel-related cases and neighbouring countries.

Methods: SARS-CoV-2 sequences in 2021-2022 from a nationwide study were included. The proportion of predominant lineages in Estonian regions and among travel-related cases was described by multinomial logistic regression. Simpson's indices of diversity were compared using linear regression. Dynamics of Bray-Curtis dissimilarity was described by applying fuzzy clustering to non-metrical dimensional scaling results.

Results: A total of 2,630 sequences from children (<15 years) and 23,031 from adults (≥15 years) were included. The increase in the proportion of Alpha/Delta/Omicron BA.1/BA.2 lineages was delayed in smaller regions (by 3.5-27.5 days). The proportion of Alpha/Delta/Omicron BA.1 increased earlier among travel-related (n = 4,654) than non-travel-related cases (10.5 days). Diversity was lower in non-travel-related than travel-related cases until Delta period by 0.066. Dynamics of lineages and diversity were similar in adults and children. Similarity of lineages was delayed compared to Finland during Alpha/Omicron BA.1/BA.2 periods and different from all neighbouring countries during Delta period.

Conclusion: SARS-CoV-2 lineages in children and adults were similar. Differences between regions and travel-related cases and varying similarity to neighbouring countries suggest the importance of mobility in the spread.

References
1.
Demakakos P . Importance of population-based longitudinal studies to understanding the impact of COVID-19. J Epidemiol Community Health. 2021; 75(9):815-816. DOI: 10.1136/jech-2021-217114. View

2.
Ferrari A, Schiavetti I, Ogliastro M, Minet C, Sibilio R, Giberti I . Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons. BMC Infect Dis. 2024; 24(1):881. PMC: 11361097. DOI: 10.1186/s12879-024-09687-1. View

3.
Khare S, Gurry C, Freitas L, Schultz M, Bach G, Diallo A . GISAID's Role in Pandemic Response. China CDC Wkly. 2021; 3(49):1049-1051. PMC: 8668406. DOI: 10.46234/ccdcw2021.255. View

4.
Yu W, Guo Y, Zhang S, Kong Y, Shen Z, Zhang J . Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis. J Med Virol. 2022; 94(12):5790-5801. PMC: 9538850. DOI: 10.1002/jmv.28066. View

5.
Anderson R, May R . The invasion, persistence and spread of infectious diseases within animal and plant communities. Philos Trans R Soc Lond B Biol Sci. 1986; 314(1167):533-70. DOI: 10.1098/rstb.1986.0072. View